Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference49 articles.
1. World Health Organization (2018) Latent tuberculosis infection—Updated and consolidated guidelines for programmatic management. https://apps.who.int/iris/handle/10665/260233 Accessed 3 April 2022
2. Iannone F, Cantini F, Lapadula G (2014) Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations. J Rheumatol Suppl 91:41–46. https://doi.org/10.3899/jrheum.140101
3. Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC et al (2016) 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68:1–26. https://doi.org/10.1002/art.39480
4. Koike R, Takeuchi T, Eguchi K, Miyasaka N, College J, of Rheumatology, (2007) Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Mod Rheumatol 17:451–458. https://doi.org/10.1007/s10165-007-0626-3
5. Australian Rheumatology Association (2018) Screening for Latent Tuberculosis Infection (LTBI) and its management in Inflammatory arthritis patients. https://rheumatology.org.au/Portals/2/Documents/Public/Professionals/SCREENINGFORLATENTTUBERCULOSISINFECTION_Jan18.pdf?ver=2021-06-28-141621-710 Accessed 3 April 2022